Araya, Helen S.
HRN: 03-27-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/22/2024
04/29/2024
IV
600mg
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes